Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study.

Bischof A. et al, (2019), Neurol neuroimmunol neuroinflamm, 6

Early development of new cardiovascular risk factors in the systemic vasculitides.

Monti S. et al, (2019), Clin exp rheumatol

Management of Takayasu arteritis: A systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis

Agueda AF. et al, (2019), Rmd open, 5

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: Focus on giant cell arteritis

Monti S. et al, (2019), Rmd open, 5

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis.

Gribbons KB. et al, (2019), Arthritis care res (hoboken)

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.

Tomasson G. et al, (2019), J rheumatol, 46, 928 - 934

2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

Hellmich B. et al, (2019), Ann rheum dis

Giant cell arteritis: new concepts, treatments and the unmet need that remains.

Coath F. et al, (2019), Rheumatology (oxford), 58

A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SIRUKUMAB IN THE TREATMENT OF PATIENTS WITH GIANT CELL ARTERITIS

Schmidt W. et al, (2019), Annals of the rheumatic diseases, 78, 827 - 827

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.

Jayne D. et al, (2019), Arthritis rheumatol, 71, 952 - 963

HOW TO ASSESS PATIENT WITH SUSPECTED VASCULITIS

Luqmani R., (2019), Annals of the rheumatic diseases, 78, 36 - 37

MANAGEMENT OF TAKAYASU ARTERITIS: A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2018 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF LARGE VESSEL VASCULITIS

Agueda AF. et al, (2019), Annals of the rheumatic diseases, 78, 421 - 422

RESULTS OF A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2018 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF LARGE VESSEL VASCULITIS: EVIDENCE TO GUIDE THE MANAGEMENT OF GIANT CELL ARTERITIS

Monti S. et al, (2019), Annals of the rheumatic diseases, 78, 823 - 823

SELF-MANAGEMENT BEHAVIOURS IN ANCA-ASSOCIATED VASCULITIS: SECONDARY ANALYSIS OF INTERVIEW DATA

Reynolds T. et al, (2019), Annals of the rheumatic diseases, 78, 1764 - 1765

THE IMPACT OF DISEASE EXTENT AND SEVERITY DETECTED BY QUANTITATIVE ULTRASOUND ANALYSIS IN THE DIAGNOSIS AND OUTCOME OF GIANT CELL ARTERITIS: RESULTS FROM THE TEMPORAL ARTERYBIOPSY VERSUS ULTRASOUND (TABUL) STUDY AND VALIDATION IN AN INDEPENDENT COHORT

Monti S. et al, (2019), Annals of the rheumatic diseases, 78, 146 - 147

WIN: VASCULITIS MAINTENANCE TREATMENT

Luqmani R., (2019), Annals of the rheumatic diseases, 78, 13 - 13

Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.

Gibson KM. et al, (2019), Arthritis rheumatol

Prevalence and Associations of Peripheral Neuropathy at Disease Onset in ANCA-Associated Vasculitides: Insights from the DCVAS Study

Bischof A. et al, (2019), Neurology, 92

A computerised system to evaluate patients with rheumatic diseases.

Luqmani R. et al, (2019), Future healthc j, 6, 80 - 81

CLASSIFICATION CRITERIA FOR THE ANCA-ASSOCIATED VASCULITIDES

Robson J. et al, (2019), Rheumatology, 58

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?